| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38045afd53308dd9efe93805f58e0485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ed0178ccd6c515a78b0489308bedc06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35e0800566149df96a65759fb22adfe5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2010-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f3cae8366d2c3940a5a693114a94aba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af81bc4d2fd46556213b742f00651608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9d2236cdf1bbc7724b74b888925c267 |
| publicationDate |
2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010120686-A2 |
| titleOfInvention |
Methods for the diagnosis and treatment of benign prostatic hyperplasia |
| abstract |
The chemokine MCP-1 is closely associated with the development of the condition benign prostatic hyperplasia (BPH) and determination of the concentration of MCP-1 in prostatic secretions or in urine after prostatic massage, or determination of the expression of the MCP-1 gene by determination of the concentration of MCP-1 -specific mRNA can be used to specifically diagnose BPH and distinguish it from other diseases or conditions affecting the prostate, such as prostatitis and prostatic carcinoma. In addition, MCP-1 can serve as a target for therapy of BPH and agents affecting the expression or activity of MCP-1 can serve as therapeutic agents for BPH. |
| priorityDate |
2009-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |